Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 792

1.

A Phase II Trial Evaluating The Efficacy of High-Dose Radioiodinated Tositumomab (Anti-CD20) Antibody, Etoposide and Cyclophosphamide followed by Autologous Transplantation, for High-Risk Relapsed or Refractory Non-Hodgkin's Lymphoma.

Chow VA, Rajendran JG, Fisher DR, Appelbaum FR, Cassaday RD, Martin PS, Holmberg LA, Gooley TA, Stevenson PA, Pagel JM, Green DJ, Press OW, Gopal AK.

Am J Hematol. 2020 Apr 3. doi: 10.1002/ajh.25818. [Epub ahead of print]

PMID:
32243637
2.

Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study.

Sollie S, Santaolalla A, Michaud DS, Sarker D, Karagiannis SN, Josephs DH, Hammar N, Walldius G, Garmo H, Holmberg L, Jungner I, Van Hemelrijck M.

Front Oncol. 2020 Feb 28;10:263. doi: 10.3389/fonc.2020.00263. eCollection 2020.

3.

Duration of sick leave after active surveillance, surgery or radiotherapy for localised prostate cancer: a nationwide cohort study.

Plym A, Clements M, Voss M, Holmberg L, Stattin P, Lambe M.

BMJ Open. 2020 Mar 9;10(3):e032914. doi: 10.1136/bmjopen-2019-032914.

4.

Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control study.

Beckmann K, Garmo H, Lindahl B, Holmberg L, Stattin P, Adolfsson J, Cruickshank JK, Van Hemelrijck M.

Prostate Cancer Prostatic Dis. 2020 Mar 2. doi: 10.1038/s41391-020-0220-8. [Epub ahead of print]

PMID:
32123316
5.

Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study.

Thomsen FB, Westerberg M, Garmo H, Robinson D, Holmberg L, Ulmert HD, Stattin P.

PLoS One. 2020 Jan 29;15(1):e0228447. doi: 10.1371/journal.pone.0228447. eCollection 2020.

6.

Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control study.

Valachis A, Garmo H, Fredriksson I, Sund M, Lagerqvist B, Holmberg L.

Breast J. 2020 Jan 28. doi: 10.1111/tbj.13759. [Epub ahead of print]

PMID:
31989762
7.

Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the "ATRESS" phenomenon.

Jurrius P, Green T, Garmo H, Young M, Cariati M, Gillett C, Mera A, Harries M, Grigoriadis A, Pinder S, Holmberg L, Purushotham A.

Breast. 2020 Apr;50:39-48. doi: 10.1016/j.breast.2020.01.006. Epub 2020 Jan 14.

8.

Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohort.

Wennstig AK, Wadsten C, Garmo H, Fredriksson I, Blomqvist C, Holmberg L, Nilsson G, Sund M.

Breast Cancer Res. 2020 Jan 22;22(1):10. doi: 10.1186/s13058-020-1249-2.

9.

Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study.

Bergengren O, Garmo H, Bratt O, Holmberg L, Johansson E, Bill-Axelson A.

BMJ Open. 2019 Dec 23;9(12):e033944. doi: 10.1136/bmjopen-2019-033944.

10.

Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden.

George G, Garmo H, Rudman S, Holmberg L, Robinson D, Stattin P, Adolfsson J, Van Hemelrijck M.

Scand J Urol. 2020 Feb;54(1):20-26. doi: 10.1080/21681805.2019.1702093. Epub 2019 Dec 16.

PMID:
31842658
11.

Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe).

Aljabery F, Liedberg F, Häggström C, Ströck V, Hosseini A, Gårdmark T, Sherif A, Jerlström T, Malmström PU, Holmberg L, Hagberg O, Jahnson S.

Scand J Urol. 2019 Oct;53(5):332-338. doi: 10.1080/21681805.2019.1681504. Epub 2019 Oct 30.

PMID:
31663405
12.

Survivorship after Autologous Hematopoietic Cell Transplantation for Lymphoma and Multiple Myeloma: Late Effects and Quality of Life.

Georges GE, Bar M, Onstad L, Yi JC, Shadman M, Flowers ME, Carpenter PA, Stewart S, Lee SJ, Holmberg LA.

Biol Blood Marrow Transplant. 2020 Feb;26(2):407-412. doi: 10.1016/j.bbmt.2019.10.002. Epub 2019 Oct 9.

PMID:
31605822
13.

No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritis.

Hailer NP, Garland A, Gordon M, Kärrholm J, Sköldenberg O, Eriksson N, Garmo H, Holmberg L.

Int J Cancer. 2019 Oct 8. doi: 10.1002/ijc.32711. [Epub ahead of print]

PMID:
31595487
14.

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.

Kumar SK, Callander NS, Hillengass J, Liedtke M, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Cornell RF, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Holmberg L, Htut M, Huff CA, Kang Y, Landgren O, Malek E, Martin T, Omel J, Raje N, Sborov D, Singhal S, Stockerl-Goldstein K, Tan C, Weber D, Johnson-Chilla A, Keller J, Kumar R.

J Natl Compr Canc Netw. 2019 Oct 1;17(10):1154-1165. doi: 10.6004/jnccn.2019.0049.

PMID:
31590151
15.

Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma.

Cassaday RD, Press OW, Pagel JM, Rajendran JG, Gooley TA, Fisher DR, Holmberg LA, Miyaoka RS, Sandmaier BM, Green DJ, Gopal AK.

Clin Cancer Res. 2019 Dec 1;25(23):6932-6938. doi: 10.1158/1078-0432.CCR-19-1567. Epub 2019 Sep 3.

PMID:
31481510
16.

Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation.

Sabloff M, Chhabra S, Wang T, Fretham C, Kekre N, Abraham A, Adekola K, Auletta JJ, Barker C, Beitinjaneh AM, Bredeson C, Cahn JY, Diaz MA, Freytes C, Gale RP, Ganguly S, Gergis U, Guinan E, Hamilton BK, Hashmi S, Hematti P, Hildebrandt G, Holmberg L, Hong S, Lazarus HM, Martino R, Muffly L, Nishihori T, Perales MA, Yared J, Mineishi S, Stadtmauer EA, Pasquini MC, Loren AW.

Biol Blood Marrow Transplant. 2019 Dec;25(12):2398-2407. doi: 10.1016/j.bbmt.2019.08.012. Epub 2019 Aug 29.

PMID:
31473319
17.

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.

Sollie S, Michaud DS, Sarker D, Karagiannis SN, Josephs DH, Hammar N, Santaolalla A, Walldius G, Garmo H, Holmberg L, Jungner I, Van Hemelrijck M.

BMC Cancer. 2019 Aug 29;19(1):858. doi: 10.1186/s12885-019-6082-6.

18.

PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design.

Ahlberg MS, Adami HO, Beckmann K, Bertilsson H, Bratt O, Cahill D, Egevad L, Garmo H, Holmberg L, Johansson E, Rannikko A, Van Hemelrijck M, Jäderling F, Wassberg C, Åberg UWN, Bill-Axelson A.

BMJ Open. 2019 Aug 22;9(8):e027860. doi: 10.1136/bmjopen-2018-027860.

19.

Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma.

Holmberg LA, Green D, Libby E, Becker PS.

Acta Haematol. 2020;143(2):146-154. doi: 10.1159/000501298. Epub 2019 Aug 21.

PMID:
31434076
20.

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis.

Santaolalla A, Garmo H, Grigoriadis A, Ghuman S, Hammar N, Jungner I, Walldius G, Lambe M, Holmberg L, Van Hemelrijck M.

BMC Mol Cell Biol. 2019 Jul 23;20(1):28. doi: 10.1186/s12860-019-0210-7.

21.

Chronic inflammatory diseases, anti-inflammatory medications and risk of prostate cancer: a population-based case-control study.

Beckmann K, Russell B, Josephs D, Garmo H, Haggstrom C, Holmberg L, Stattin P, Van Hemelrijck M, Adolfsson J.

BMC Cancer. 2019 Jun 21;19(1):612. doi: 10.1186/s12885-019-5846-3.

22.

Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe).

Jahnson S, Gårdmark T, Hosseini A, Jerlström T, Liedberg F, Malmström PU, Rosell J, Sherif A, Ströck V, Häggström C, Holmberg L, Aljabery F.

Scand J Urol. 2019 Aug;53(4):200-205. doi: 10.1080/21681805.2019.1621377. Epub 2019 May 30.

PMID:
31144582
23.

Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial.

Johansson E, Steineck G, Holmberg L, Johansson JE, Nyberg T, Bill-Axelson A; SPCG-4 Investigators.

Eur Urol Oncol. 2018 Jun;1(2):134-142. doi: 10.1016/j.euo.2018.03.003. Epub 2018 May 15.

PMID:
31100237
24.

Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study.

Bergengren O, Garmo H, Bratt O, Holmberg L, Johansson E, Bill-Axelson A.

Eur Urol Oncol. 2018 May;1(1):37-45. doi: 10.1016/j.euo.2018.02.003. Epub 2018 May 15.

PMID:
31100227
25.

A prospective stepped wedge cohort evaluation of the new national trauma team activation criteria in Sweden - the TRAUMALERT study.

Linder F, Holmberg L, Bjorck M, Juhlin C, Thorbjornsen K, Wisinger J, Polleryd P, Eklof H, Mani K.

Scand J Trauma Resusc Emerg Med. 2019 Apr 30;27(1):52. doi: 10.1186/s13049-019-0619-1.

26.

Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort.

Essén A, Santaolalla A, Garmo H, Hammar N, Walldius G, Jungner I, Malmström H, Holmberg L, Van Hemelrijck M.

Cancer Causes Control. 2019 Jun;30(6):603-615. doi: 10.1007/s10552-019-01170-6. Epub 2019 Apr 24.

PMID:
31020446
27.

Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study.

Liedberg F, Hagberg O, Aljabery F, Gårdmark T, Hosseini A, Jahnson S, Jancke G, Jerlström T, Malmström PU, Sherif A, Ströck V, Häggström C, Holmberg L.

BJU Int. 2019 Sep;124(3):449-456. doi: 10.1111/bju.14767. Epub 2019 Apr 22.

PMID:
30950568
28.

Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study.

Häggström C, Garmo H, de Luna X, Van Hemelrijck M, Söderkvist K, Aljabery F, Ströck V, Hosseini A, Gårdmark T, Malmström PU, Jahnson S, Liedberg F, Holmberg L.

Cancer Med. 2019 May;8(5):2196-2204. doi: 10.1002/cam4.2126. Epub 2019 Apr 1.

29.

Radical Surgery or Watchful Waiting in Prostate Cancer. Reply.

Bill-Axelson A, Holmberg L, Garmo H.

N Engl J Med. 2019 Mar 14;380(11):1084. doi: 10.1056/NEJMc1900410. No abstract available.

PMID:
30865809
30.

Causes of sick leave, disability pension, and death following a breast cancer diagnosis in women of working age.

Plym A, Johansson ALV, Bower H, Voss M, Holmberg L, Fredriksson I, Lambe M.

Breast. 2019 Jun;45:48-55. doi: 10.1016/j.breast.2019.02.012. Epub 2019 Mar 2.

PMID:
30852409
31.

The relationship between radiation doses to coronary arteries and location of coronary stenosis requiring intervention in breast cancer survivors.

Wennstig AK, Garmo H, Isacsson U, Gagliardi G, Rintelä N, Lagerqvist B, Holmberg L, Blomqvist C, Sund M, Nilsson G.

Radiat Oncol. 2019 Mar 7;14(1):40. doi: 10.1186/s13014-019-1242-z.

32.

Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.

Kilari D, D'Souza A, Fraser R, Qayed M, Davila O, Agrawal V, Diaz MA, Chhabra S, Cerny J, Copelan E, Farhadfar N, Freytes CO, Gale RP, Ganguly S, Hildebrandt GC, Holmberg L, Kamble RT, Kapoor P, Lazarus H, Lee C, Murthy HS, Naik S, Nishihori T, Saad A, Savani BN, Seo S, Warwick A, Wirk B, Yared JA, Nieto Y, Hari P.

Biol Blood Marrow Transplant. 2019 Jun;25(6):1099-1106. doi: 10.1016/j.bbmt.2019.02.015. Epub 2019 Feb 20.

PMID:
30794931
33.

Androgen deprivation therapy for prostate cancer and risk of dementia.

Robinson D, Garmo H, Van Hemelrijck M, Damber JE, Bratt O, Holmberg L, Wahlund LO, Stattin P, Adolfsson J.

BJU Int. 2019 Jul;124(1):87-92. doi: 10.1111/bju.14666. Epub 2019 Feb 6.

34.

Radical Prostatectomy or Watchful Waiting in Prostate Cancer - 29-Year Follow-up.

Bill-Axelson A, Holmberg L, Garmo H, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Andrén O, Steineck G, Adami HO, Johansson JE.

N Engl J Med. 2018 Dec 13;379(24):2319-2329. doi: 10.1056/NEJMoa1807801.

PMID:
30575473
35.

Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer.

Beckmann K, Garmo H, Adolfsson J, Bosco C, Johansson E, Robinson D, Holmberg L, Stattin P, Van Hemelrijck M.

Eur Urol. 2019 Apr;75(4):676-683. doi: 10.1016/j.eururo.2018.11.022. Epub 2018 Nov 26.

PMID:
30497883
36.

Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.

Brunstein CG, Pasquini MC, Kim S, Fei M, Adekola K, Ahmed I, Aljurf M, Agrawal V, Auletta JJ, Battiwalla M, Bejanyan N, Bubalo J, Cerny J, Chee L, Ciurea SO, Freytes C, Gadalla SM, Gale RP, Ganguly S, Hashmi SK, Hematti P, Hildebrandt G, Holmberg LA, Lahoud OB, Landau H, Lazarus HM, de Lima M, Mathews V, Maziarz R, Nishihori T, Norkin M, Olsson R, Reshef R, Rotz S, Savani B, Schouten HC, Seo S, Wirk BM, Yared J, Mineishi S, Rogosheske J, Perales MA.

Biol Blood Marrow Transplant. 2019 Mar;25(3):480-487. doi: 10.1016/j.bbmt.2018.11.005. Epub 2018 Nov 10.

37.

Serum glucose, triglycerides, and cholesterol in relation to prostate cancer death in the Swedish AMORIS study.

Arthur R, Møller H, Garmo H, Häggström C, Holmberg L, Stattin P, Malmström H, Lambe M, Hammar N, Walldius G, Robinson D, Jungner I, Van Hemelrijck M.

Cancer Causes Control. 2019 Feb;30(2):195-206. doi: 10.1007/s10552-018-1093-1. Epub 2018 Nov 12.

PMID:
30421156
38.

Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study.

Birgegård G, Folkvaljon F, Garmo H, Holmberg L, Besses C, Griesshammer M, Gugliotta L, Wu J, Achenbach H, Kiladjian JJ, Harrison CN.

Leuk Res. 2018 Nov;74:105-109. doi: 10.1016/j.leukres.2018.10.006. Epub 2018 Oct 11.

PMID:
30368038
39.

Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma.

Greenbaum AM, Green DJ, Holmberg LA, Gooley T, Till BG, Budde LE, Rasmussen H, Press OW, Gopal AK.

Blood Res. 2018 Sep;53(3):223-226. doi: 10.5045/br.2018.53.3.223. Epub 2018 Sep 28.

40.

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.

Maffini E, Storer BE, Sandmaier BM, Bruno B, Sahebi F, Shizuru JA, Chauncey TR, Hari P, Lange T, Pulsipher MA, McSweeney PA, Holmberg L, Becker PS, Green DJ, Mielcarek M, Maloney DG, Storb R.

Haematologica. 2019 Feb;104(2):380-391. doi: 10.3324/haematol.2018.200253. Epub 2018 Sep 27.

41.

Mortality after radical prostatectomy in a matched contemporary cohort in Sweden compared to the Scandinavian Prostate Cancer Group 4 (SPCG-4) study.

Cazzaniga W, Garmo H, Robinson D, Holmberg L, Bill-Axelson A, Stattin P.

BJU Int. 2019 Mar;123(3):421-428. doi: 10.1111/bju.14563. Epub 2018 Oct 25.

42.

Ghrelin expression is associated with a favorable outcome in male breast cancer.

Grönberg M, Nilsson C, Markholm I, Hedenfalk I, Blomqvist C, Holmberg L, Tiensuu Janson E, Fjällskog ML.

Sci Rep. 2018 Sep 11;8(1):13586. doi: 10.1038/s41598-018-31783-x.

43.

Good prognosis following a PSA bounce after high dose rate brachytherapy and external radiotherapy in prostate cancer.

Åström L, Sandin F, Holmberg L.

Radiother Oncol. 2018 Dec;129(3):561-566. doi: 10.1016/j.radonc.2018.08.011. Epub 2018 Sep 4.

PMID:
30193693
44.

Influence of the subtype on local recurrence risk of breast cancer with or without radiation therapy.

Wickberg Å, Magnuson A, Holmberg L, Adami HO, Liljegren G.

Breast. 2018 Dec;42:54-60. doi: 10.1016/j.breast.2018.08.097. Epub 2018 Aug 21.

PMID:
30176553
45.

Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups.

Scott EC, Hari P, Kumar S, Fraser R, Davila O, Shah N, Gale RP, Diaz MA, Agrawal V, Cornell RF, Ganguly S, Akpek G, Freytes C, Hashmi S, Malek E, Kamble RT, Lazarus H, Solh M, Usmani SZ, Kanate AS, Saad A, Chhabra S, Gergis U, Cerny J, Kyle RA, Lee C, Kindwall-Keller T, Assal A, Hildebrandt GC, Holmberg L, Maziarz RT, Nishihori T, Seo S, Kumar S, Mark T, D'Souza A.

Biol Blood Marrow Transplant. 2018 Dec;24(12):2443-2449. doi: 10.1016/j.bbmt.2018.08.013. Epub 2018 Aug 22.

46.

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity.

Wulaningsih W, Garmo H, Ahlgren J, Holmberg L, Folkvaljon Y, Wigertz A, Van Hemelrijck M, Lambe M.

Breast Cancer Res Treat. 2018 Nov;172(1):167-177. doi: 10.1007/s10549-018-4890-z. Epub 2018 Jul 21.

47.

Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. Chen.

Pettersson A, Robinson D, Garmo H, Holmberg L, Stattin P.

Ann Oncol. 2018 Sep 1;29(9):2020-2021. doi: 10.1093/annonc/mdy236. No abstract available.

48.

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.

Chen RW, Palmer JM, Tomassetti S, Popplewell LL, Alluin J, Chomchan P, Nademanee AP, Siddiqi T, Tsai NC, Chen L, Zuo F, Abary R, Cai JL, Herrera AF, Rossi JJ, Rosen ST, Forman SJ, Kwak LW, Holmberg LA.

J Hematol Oncol. 2018 Jun 28;11(1):87. doi: 10.1186/s13045-018-0631-3.

49.

Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus.

Häggström C, Van Hemelrijck M, Garmo H, Robinson D, Stattin P, Rowley M, Coolen ACC, Holmberg L.

Int J Cancer. 2018 Oct 15;143(8):1868-1875. doi: 10.1002/ijc.31587. Epub 2018 Aug 10.

50.

Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situ.

Wadsten C, Wennstig AK, Garmo H, Nilsson G, Blomqvist C, Holmberg L, Fredriksson I, Wärnberg F, Sund M.

Breast Cancer Res Treat. 2018 Aug;171(1):95-101. doi: 10.1007/s10549-018-4803-1. Epub 2018 May 5.

PMID:
29730730

Supplemental Content

Loading ...
Support Center